COMPLETED

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Talk to us

Conditions

Type1diabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to find out how bones are affected in children and adolescents with type 1 diabetes (T1D) as compared to children and adolescents without type 1 diabetes.

Official Title

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Quick Facts

Study Start:2020-01-01
Study Completion:2025-09-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04289727

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 14 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Estimated glomerular filtration rate (eGFR)\< 60 ml/mim
  2. * 25(OH)D level \< 20 ng/ml.
  3. * Celiac disease
  4. * Autoimmune thyroid disease
  5. * Addison's disease
  6. * History of pathological fractures
  7. * Bone active drugs in past year
  8. * Diabetes of other or unclear etiology

Contacts and Locations

Principal Investigator

Mishaela Rubin, MD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University Medical Center-Harkness Pavillion
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Mishaela Rubin, MD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-01
Study Completion Date2025-09-08

Study Record Updates

Study Start Date2020-01-01
Study Completion Date2025-09-08

Terms related to this study

Additional Relevant MeSH Terms

  • Type1diabetes